You are here:Home-Chemical Inhibitors & Agonists-Cell Cycle/DNA Damage-PARP-AZD9574
AZD9574

Chemical Structure : AZD9574

CAS No.: 2756333-39-6

AZD9574 (AZD-9574, AZD 9574)

Catalog No.: PC-72899Not For Human Use, Lab Use Only.

AZD9574 (AZD-9574) is a potent, selective and CNS penetrant PARP1 inhibitor, inhibits PARP1 enzymatic activity with IC50 of 0.3-2.0 nM in a panel of cell lines irrespective of the HRR status.

Packing Price Stock Quantity
5 mg $298 In stock
10 mg $488 In stock
25 mg $798 In stock
100 mg Get quote
1 g Get quote

Bulk size, bulk discount!

E-mail: sales@probechem.com

Tech Support: tech@probechem.com

Purity & Documentation Purity: 98.58% Select Batch:

Biological Activity

AZD9574 (AZD-9574) is a potent, selective and CNS penetrant PARP1 inhibitor, inhibits PARP1 enzymatic activity with IC50 of 0.3-2.0 nM in a panel of cell lines irrespective of the HRR status.
AZD9574 acts by selectively inhibiting and trapping PARP1 at the sites of SSBs.
AZD9574 exhibits >8000-fold selectivity for PARP1 compared to PARP2 and other members of the PARP family (PARP2, PARP3, PARP5a and PARP6) in biochemical assays.
AZD9574 inhibits colony formation assay in isogenic cell lines pairs confirmed higher potency and selectivity towards HRD+ models (DLD1 BRCA2-/-; SKOV-3 BRCA2-/- and SKOV-3 PALB2-/-), inhibits BRCA2-/- DLD1 cells with IC50 of 1.38 nM, and shows no effect against BRCA2wt cells.
AZD9574 demonstrated dose-dependent efficacy in a BRCA1 mutant MDA-MB-436 subcutaneous xenograft model. AZD9574 (3 mg/kg) showed sustained tumour growth suppression resulting in a significantly extended survival of tumour-bearing intracranial xenograft model of breast cancer brain metastases.

Physicochemical Properties

M.Wt 428.44
Formula C21H22F2N6O2
Appearance Solid
CAS No.
Storage
Solide Powder
-20°C 12 Months; 4°C 6 Months
In Solvent
-80°C 6 Months; -20°C 6 Months
Shipping
Solubility

10 mM in DMSO

Chemical Name/SMILES

6-fluoro-5-(4-((5-fluoro-2-methyl-3-oxo-3,4-dihydroquinoxalin-6-yl)methyl)piperazin-1-yl)-N-methylpicolinamide

References

1. Kunzah Jamal, et al. Cancer Res (2022) 82 (12_Supplement): 2609.

Copyright © 2022 probechem.com. All Rights Reserved. probechem Copyright

Contact Us sales@probechem.com

Bulk Inquiry

* Indicates a Required FieldYour information is safe with us.

  • *Product name:
  • *Applicant name:
  • *Email address:
  • *Organization name:
  • *Requested quantity:
  • *Country:
  • *Additional Information:

Get Quote

* Indicates a Required FieldYour information is safe with us.

  • *Product name:
  • *Applicant name:
  • *Email address:
  • *Organization name:
  • *Requested quantity:
  • *Country:
  • Additional Information: